際際滷

際際滷Share a Scribd company logo
Articulo 1
a   O2               O2.-            b      O2              O2.-


                      Nox1      p22phox                      Nox2      p22phox


        H+ + NADP+                              H+ + NADP+

           NADPH                        NOXO1       NADPH                     P47
                             NOXA1                                    P67     phox
                                                                      phox
                          Rac                                  Rac

                          GTP                                  GTP




           c         O2              H2O2       d      O2              O2.-
                             O2.-

                      Nox4          p22phox                  Nox5
                                                                    Ca2+
        H+ + NADP+                              H+ + NADP+

           NADPH                                    NADPH




    -




-
-




    tat
-                     -




                                                                             -


                                                               -




                            a                                                    b
                                NOX1            NOX2                NOX4


                                         O2.-                        H2O2
                  -
                                                  NO

                                                       ONOO-

                                                                    Improved
                                 Vascular       Endothelial        endothelial
                                remodeling      dysfunction          function




                      top
            Ach

 Tg                   SBP
      DBP
P
.
                   --




              --

     .

         --




                              .


          .




              --




                          -
--




                        tat
b




                .
    a   a




j
a
     WT/Sham          KO/Sham      WT/Band      KO/Band
A




B




C




 b        Stress (hypertension)


            Myocardial hypoxia
                                               Preservation of
                                                 capillaries


                       Hydroxylated HIF-1留

     Nox4
                       stable HIF-1留


                 HIF-1 complex               VEGF
                      留 硫
                 VEGF-HRE




                      WT
            Panel A                             scale bar
panel B
                                 panel C
                                              scale bars    l


                 .
WT



.




         .
--
Articulo 1
--
-
Articulo 1

More Related Content

Viewers also liked (11)

Diapositiva joel qui単onesDiapositiva joel qui単ones
Diapositiva joel qui単ones
joelqui
Diapositiva joel qui単ones (3)Diapositiva joel qui単ones (3)
Diapositiva joel qui単ones (3)
joelqui
Peter Mackey Philosophy of Learning
Peter Mackey Philosophy of LearningPeter Mackey Philosophy of Learning
Peter Mackey Philosophy of Learning
pmackey11
Diapositiva joel qui単ones (3)Diapositiva joel qui単ones (3)
Diapositiva joel qui単ones (3)
joelqui
Peter mackey Philosophy of Learning
Peter mackey Philosophy of LearningPeter mackey Philosophy of Learning
Peter mackey Philosophy of Learning
pmackey11
P.s.q
P.s.qP.s.q
P.s.q
M坦nica Gilbert-S叩ez
How to learn
How to learnHow to learn
How to learn
pmackey11
Mackey digital photo powerpoint
Mackey digital photo powerpointMackey digital photo powerpoint
Mackey digital photo powerpoint
pmackey11
Smart Room Justification
Smart Room JustificationSmart Room Justification
Smart Room Justification
pmackey11
巽Oklu zeka slayt
巽Oklu zeka slayt巽Oklu zeka slayt
巽Oklu zeka slayt
hasanboran
Exciting marketing research notes
Exciting marketing research notesExciting marketing research notes
Exciting marketing research notes
Anastasia Mishurova
Diapositiva joel qui単onesDiapositiva joel qui単ones
Diapositiva joel qui単ones
joelqui
Diapositiva joel qui単ones (3)Diapositiva joel qui単ones (3)
Diapositiva joel qui単ones (3)
joelqui
Peter Mackey Philosophy of Learning
Peter Mackey Philosophy of LearningPeter Mackey Philosophy of Learning
Peter Mackey Philosophy of Learning
pmackey11
Diapositiva joel qui単ones (3)Diapositiva joel qui単ones (3)
Diapositiva joel qui単ones (3)
joelqui
Peter mackey Philosophy of Learning
Peter mackey Philosophy of LearningPeter mackey Philosophy of Learning
Peter mackey Philosophy of Learning
pmackey11
How to learn
How to learnHow to learn
How to learn
pmackey11
Mackey digital photo powerpoint
Mackey digital photo powerpointMackey digital photo powerpoint
Mackey digital photo powerpoint
pmackey11
Smart Room Justification
Smart Room JustificationSmart Room Justification
Smart Room Justification
pmackey11
巽Oklu zeka slayt
巽Oklu zeka slayt巽Oklu zeka slayt
巽Oklu zeka slayt
hasanboran
Exciting marketing research notes
Exciting marketing research notesExciting marketing research notes
Exciting marketing research notes
Anastasia Mishurova

Similar to Articulo 1 (20)

Session 4 part 3
Session 4 part 3Session 4 part 3
Session 4 part 3
plmiami
HIF in cell Biology & Physiology
HIF in cell Biology & PhysiologyHIF in cell Biology & Physiology
HIF in cell Biology & Physiology
MAASTRO clinic
Principles of 3D Fitting of Molecules
Principles of 3D Fitting of MoleculesPrinciples of 3D Fitting of Molecules
Principles of 3D Fitting of Molecules
MAASTRO clinic
12.11.08: Folate Metabolism
12.11.08: Folate Metabolism12.11.08: Folate Metabolism
12.11.08: Folate Metabolism
Open.Michigan
12.11.08: Folate Metabolism
12.11.08: Folate Metabolism12.11.08: Folate Metabolism
12.11.08: Folate Metabolism
Open.Michigan
Design Of New Rac1 Inhibitors Through Computational Approaches
Design Of New Rac1 Inhibitors Through Computational ApproachesDesign Of New Rac1 Inhibitors Through Computational Approaches
Design Of New Rac1 Inhibitors Through Computational Approaches
contini
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
iosrphr_editor
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
iosrphr_editor
Lecture5: 123.702
Lecture5: 123.702Lecture5: 123.702
Lecture5: 123.702
Gareth Rowlands
Human esterases: Chemical and Biochemical Considerations
Human esterases: Chemical and Biochemical ConsiderationsHuman esterases: Chemical and Biochemical Considerations
Human esterases: Chemical and Biochemical Considerations
Luke Lightning
09 terrence monks
09 terrence monks09 terrence monks
09 terrence monks
radarrt
Oxidative Phosphorylation
Oxidative PhosphorylationOxidative Phosphorylation
Oxidative Phosphorylation
Nicky Burt
Enzymes chp-6-7-bioc-361-version-oct-2012b
Enzymes chp-6-7-bioc-361-version-oct-2012bEnzymes chp-6-7-bioc-361-version-oct-2012b
Enzymes chp-6-7-bioc-361-version-oct-2012b
Jody Haddow
犖犖迦牽犖犖ム顕犖∇肩犖迦牽犖犖迦見犖迦牽犢犖僅権犢犖犢犖犖犖犖犖巌攻釣犖
犖犖迦牽犖犖ム顕犖∇肩犖迦牽犖犖迦見犖迦牽犢犖僅権犢犖犢犖犖犖犖犖巌攻釣犖犖犖迦牽犖犖ム顕犖∇肩犖迦牽犖犖迦見犖迦牽犢犖僅権犢犖犢犖犖犖犖犖巌攻釣犖
犖犖迦牽犖犖ム顕犖∇肩犖迦牽犖犖迦見犖迦牽犢犖僅権犢犖犢犖犖犖犖犖巌攻釣犖
Thanyamon Chat.
4.ly korea
4.ly korea4.ly korea
4.ly korea
drugmetabol
Metabolic pathways poster
Metabolic pathways posterMetabolic pathways poster
Metabolic pathways poster
GiovanneSouza4
Acs 2010 San Fransico
Acs 2010 San FransicoAcs 2010 San Fransico
Acs 2010 San Fransico
Karen Sanders
Mannich reaction (1)
Mannich reaction (1)Mannich reaction (1)
Mannich reaction (1)
Shreesha Bhat
Single multifunctional organocatalyst
Single multifunctional organocatalystSingle multifunctional organocatalyst
Single multifunctional organocatalyst
Ly Nguyen Hai Du
Personalized Medicine Approaches in Oncology
Personalized Medicine Approaches in OncologyPersonalized Medicine Approaches in Oncology
Personalized Medicine Approaches in Oncology
John Theurer Cancer Center at Hackensack University Medical Center
Session 4 part 3
Session 4 part 3Session 4 part 3
Session 4 part 3
plmiami
HIF in cell Biology & Physiology
HIF in cell Biology & PhysiologyHIF in cell Biology & Physiology
HIF in cell Biology & Physiology
MAASTRO clinic
Principles of 3D Fitting of Molecules
Principles of 3D Fitting of MoleculesPrinciples of 3D Fitting of Molecules
Principles of 3D Fitting of Molecules
MAASTRO clinic
12.11.08: Folate Metabolism
12.11.08: Folate Metabolism12.11.08: Folate Metabolism
12.11.08: Folate Metabolism
Open.Michigan
12.11.08: Folate Metabolism
12.11.08: Folate Metabolism12.11.08: Folate Metabolism
12.11.08: Folate Metabolism
Open.Michigan
Design Of New Rac1 Inhibitors Through Computational Approaches
Design Of New Rac1 Inhibitors Through Computational ApproachesDesign Of New Rac1 Inhibitors Through Computational Approaches
Design Of New Rac1 Inhibitors Through Computational Approaches
contini
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
iosrphr_editor
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
iosrphr_editor
Human esterases: Chemical and Biochemical Considerations
Human esterases: Chemical and Biochemical ConsiderationsHuman esterases: Chemical and Biochemical Considerations
Human esterases: Chemical and Biochemical Considerations
Luke Lightning
09 terrence monks
09 terrence monks09 terrence monks
09 terrence monks
radarrt
Oxidative Phosphorylation
Oxidative PhosphorylationOxidative Phosphorylation
Oxidative Phosphorylation
Nicky Burt
Enzymes chp-6-7-bioc-361-version-oct-2012b
Enzymes chp-6-7-bioc-361-version-oct-2012bEnzymes chp-6-7-bioc-361-version-oct-2012b
Enzymes chp-6-7-bioc-361-version-oct-2012b
Jody Haddow
犖犖迦牽犖犖ム顕犖∇肩犖迦牽犖犖迦見犖迦牽犢犖僅権犢犖犢犖犖犖犖犖巌攻釣犖
犖犖迦牽犖犖ム顕犖∇肩犖迦牽犖犖迦見犖迦牽犢犖僅権犢犖犢犖犖犖犖犖巌攻釣犖犖犖迦牽犖犖ム顕犖∇肩犖迦牽犖犖迦見犖迦牽犢犖僅権犢犖犢犖犖犖犖犖巌攻釣犖
犖犖迦牽犖犖ム顕犖∇肩犖迦牽犖犖迦見犖迦牽犢犖僅権犢犖犢犖犖犖犖犖巌攻釣犖
Thanyamon Chat.
Metabolic pathways poster
Metabolic pathways posterMetabolic pathways poster
Metabolic pathways poster
GiovanneSouza4
Acs 2010 San Fransico
Acs 2010 San FransicoAcs 2010 San Fransico
Acs 2010 San Fransico
Karen Sanders
Mannich reaction (1)
Mannich reaction (1)Mannich reaction (1)
Mannich reaction (1)
Shreesha Bhat
Single multifunctional organocatalyst
Single multifunctional organocatalystSingle multifunctional organocatalyst
Single multifunctional organocatalyst
Ly Nguyen Hai Du
Ad

Recently uploaded (20)

Peripheral Retinal Degenerations. pptxxx
Peripheral Retinal Degenerations. pptxxxPeripheral Retinal Degenerations. pptxxx
Peripheral Retinal Degenerations. pptxxx
Dr. Geetika Singh
Radiological approach to Lung Carcinoma: A 2025 update
Radiological approach to Lung Carcinoma:  A 2025 updateRadiological approach to Lung Carcinoma:  A 2025 update
Radiological approach to Lung Carcinoma: A 2025 update
Dr. Aryan (Anish Dhakal)
Why Dental Implants Fail Quality Care for Your Smile
Why Dental Implants Fail Quality Care for Your SmileWhy Dental Implants Fail Quality Care for Your Smile
Why Dental Implants Fail Quality Care for Your Smile
Reveal Dental
REFRAMING OF EXPERTISE AND INFORMATION IN HEALTH
REFRAMING OF EXPERTISE AND INFORMATION IN HEALTHREFRAMING OF EXPERTISE AND INFORMATION IN HEALTH
REFRAMING OF EXPERTISE AND INFORMATION IN HEALTH
Tina Purnat
Interstitial brachytherapy in Ca CERVIX.pptx
Interstitial brachytherapy in Ca CERVIX.pptxInterstitial brachytherapy in Ca CERVIX.pptx
Interstitial brachytherapy in Ca CERVIX.pptx
Brijesh Maheshwari
cryptococcus.pptxcryptococcus.pptxcryptococcus.pptx
cryptococcus.pptxcryptococcus.pptxcryptococcus.pptxcryptococcus.pptxcryptococcus.pptxcryptococcus.pptx
cryptococcus.pptxcryptococcus.pptxcryptococcus.pptx
VaisHali822687
Treatment for HFpEF: Current State of the Art and Ongoing Trials
Treatment for HFpEF: Current State of the Art and Ongoing TrialsTreatment for HFpEF: Current State of the Art and Ongoing Trials
Treatment for HFpEF: Current State of the Art and Ongoing Trials
Duke Heart
Soft Tissue Level 1 Course by Elite Akademy Sports Medicine | Kusal Goonewardena
Soft Tissue Level 1 Course by Elite Akademy Sports Medicine | Kusal GoonewardenaSoft Tissue Level 1 Course by Elite Akademy Sports Medicine | Kusal Goonewardena
Soft Tissue Level 1 Course by Elite Akademy Sports Medicine | Kusal Goonewardena
Kusal Goonewardena
GENITOUzesxrctvybhmkl;hbjkRINARY SYSTEM DISORDERS.ppt
GENITOUzesxrctvybhmkl;hbjkRINARY SYSTEM DISORDERS.pptGENITOUzesxrctvybhmkl;hbjkRINARY SYSTEM DISORDERS.ppt
GENITOUzesxrctvybhmkl;hbjkRINARY SYSTEM DISORDERS.ppt
FREDRICK CIIRA
Quality of Life in CHF & Patient Preferences
Quality of Life in CHF & Patient PreferencesQuality of Life in CHF & Patient Preferences
Quality of Life in CHF & Patient Preferences
Duke Heart
THE EYELID PPT FOR 1ST YEAR BSC OPTOMETRY
THE EYELID PPT FOR 1ST YEAR BSC OPTOMETRYTHE EYELID PPT FOR 1ST YEAR BSC OPTOMETRY
THE EYELID PPT FOR 1ST YEAR BSC OPTOMETRY
nihalanichz
Congestion Management in the Hospital Setting
Congestion Management in the Hospital SettingCongestion Management in the Hospital Setting
Congestion Management in the Hospital Setting
Duke Heart
State of the Art LVAD Care: What Does the Year 2025 Bring?
State of the Art LVAD Care: What Does the Year 2025 Bring?State of the Art LVAD Care: What Does the Year 2025 Bring?
State of the Art LVAD Care: What Does the Year 2025 Bring?
Duke Heart
JAUNDICE,BIOCHEMISTRY, FIRST MBBS STUDENTS
JAUNDICE,BIOCHEMISTRY, FIRST MBBS STUDENTSJAUNDICE,BIOCHEMISTRY, FIRST MBBS STUDENTS
JAUNDICE,BIOCHEMISTRY, FIRST MBBS STUDENTS
amitarathore081986
Remembering Brain Health: Reshaping Care Models to Achieve Meaningful Impact ...
Remembering Brain Health: Reshaping Care Models to Achieve Meaningful Impact ...Remembering Brain Health: Reshaping Care Models to Achieve Meaningful Impact ...
Remembering Brain Health: Reshaping Care Models to Achieve Meaningful Impact ...
PVI, PeerView Institute for Medical Education
How Has Our Understanding of Heart Failure with Preserved Ejection Fraction E...
How Has Our Understanding of Heart Failure with Preserved Ejection Fraction E...How Has Our Understanding of Heart Failure with Preserved Ejection Fraction E...
How Has Our Understanding of Heart Failure with Preserved Ejection Fraction E...
Duke Heart
Hepatocellular carcinoma: From diagnosis to emerging therapeutics
Hepatocellular carcinoma: From diagnosis to emerging therapeuticsHepatocellular carcinoma: From diagnosis to emerging therapeutics
Hepatocellular carcinoma: From diagnosis to emerging therapeutics
ajayyadav753
Posterior uveitis (Infective causes) Ophthalmology
Posterior uveitis (Infective causes) OphthalmologyPosterior uveitis (Infective causes) Ophthalmology
Posterior uveitis (Infective causes) Ophthalmology
nirajgoswami99999
Advances in Novel Drug Therapy for Metabolic Dysfunction-associated Steatohep...
Advances in Novel Drug Therapy for Metabolic Dysfunction-associated Steatohep...Advances in Novel Drug Therapy for Metabolic Dysfunction-associated Steatohep...
Advances in Novel Drug Therapy for Metabolic Dysfunction-associated Steatohep...
syedanasir5
Acquired Cataract classification ,risk, mechanism and stages_mbbs.pptx
Acquired Cataract classification ,risk, mechanism and stages_mbbs.pptxAcquired Cataract classification ,risk, mechanism and stages_mbbs.pptx
Acquired Cataract classification ,risk, mechanism and stages_mbbs.pptx
Sourav Choudhari
Peripheral Retinal Degenerations. pptxxx
Peripheral Retinal Degenerations. pptxxxPeripheral Retinal Degenerations. pptxxx
Peripheral Retinal Degenerations. pptxxx
Dr. Geetika Singh
Radiological approach to Lung Carcinoma: A 2025 update
Radiological approach to Lung Carcinoma:  A 2025 updateRadiological approach to Lung Carcinoma:  A 2025 update
Radiological approach to Lung Carcinoma: A 2025 update
Dr. Aryan (Anish Dhakal)
Why Dental Implants Fail Quality Care for Your Smile
Why Dental Implants Fail Quality Care for Your SmileWhy Dental Implants Fail Quality Care for Your Smile
Why Dental Implants Fail Quality Care for Your Smile
Reveal Dental
REFRAMING OF EXPERTISE AND INFORMATION IN HEALTH
REFRAMING OF EXPERTISE AND INFORMATION IN HEALTHREFRAMING OF EXPERTISE AND INFORMATION IN HEALTH
REFRAMING OF EXPERTISE AND INFORMATION IN HEALTH
Tina Purnat
Interstitial brachytherapy in Ca CERVIX.pptx
Interstitial brachytherapy in Ca CERVIX.pptxInterstitial brachytherapy in Ca CERVIX.pptx
Interstitial brachytherapy in Ca CERVIX.pptx
Brijesh Maheshwari
cryptococcus.pptxcryptococcus.pptxcryptococcus.pptx
cryptococcus.pptxcryptococcus.pptxcryptococcus.pptxcryptococcus.pptxcryptococcus.pptxcryptococcus.pptx
cryptococcus.pptxcryptococcus.pptxcryptococcus.pptx
VaisHali822687
Treatment for HFpEF: Current State of the Art and Ongoing Trials
Treatment for HFpEF: Current State of the Art and Ongoing TrialsTreatment for HFpEF: Current State of the Art and Ongoing Trials
Treatment for HFpEF: Current State of the Art and Ongoing Trials
Duke Heart
Soft Tissue Level 1 Course by Elite Akademy Sports Medicine | Kusal Goonewardena
Soft Tissue Level 1 Course by Elite Akademy Sports Medicine | Kusal GoonewardenaSoft Tissue Level 1 Course by Elite Akademy Sports Medicine | Kusal Goonewardena
Soft Tissue Level 1 Course by Elite Akademy Sports Medicine | Kusal Goonewardena
Kusal Goonewardena
GENITOUzesxrctvybhmkl;hbjkRINARY SYSTEM DISORDERS.ppt
GENITOUzesxrctvybhmkl;hbjkRINARY SYSTEM DISORDERS.pptGENITOUzesxrctvybhmkl;hbjkRINARY SYSTEM DISORDERS.ppt
GENITOUzesxrctvybhmkl;hbjkRINARY SYSTEM DISORDERS.ppt
FREDRICK CIIRA
Quality of Life in CHF & Patient Preferences
Quality of Life in CHF & Patient PreferencesQuality of Life in CHF & Patient Preferences
Quality of Life in CHF & Patient Preferences
Duke Heart
THE EYELID PPT FOR 1ST YEAR BSC OPTOMETRY
THE EYELID PPT FOR 1ST YEAR BSC OPTOMETRYTHE EYELID PPT FOR 1ST YEAR BSC OPTOMETRY
THE EYELID PPT FOR 1ST YEAR BSC OPTOMETRY
nihalanichz
Congestion Management in the Hospital Setting
Congestion Management in the Hospital SettingCongestion Management in the Hospital Setting
Congestion Management in the Hospital Setting
Duke Heart
State of the Art LVAD Care: What Does the Year 2025 Bring?
State of the Art LVAD Care: What Does the Year 2025 Bring?State of the Art LVAD Care: What Does the Year 2025 Bring?
State of the Art LVAD Care: What Does the Year 2025 Bring?
Duke Heart
JAUNDICE,BIOCHEMISTRY, FIRST MBBS STUDENTS
JAUNDICE,BIOCHEMISTRY, FIRST MBBS STUDENTSJAUNDICE,BIOCHEMISTRY, FIRST MBBS STUDENTS
JAUNDICE,BIOCHEMISTRY, FIRST MBBS STUDENTS
amitarathore081986
How Has Our Understanding of Heart Failure with Preserved Ejection Fraction E...
How Has Our Understanding of Heart Failure with Preserved Ejection Fraction E...How Has Our Understanding of Heart Failure with Preserved Ejection Fraction E...
How Has Our Understanding of Heart Failure with Preserved Ejection Fraction E...
Duke Heart
Hepatocellular carcinoma: From diagnosis to emerging therapeutics
Hepatocellular carcinoma: From diagnosis to emerging therapeuticsHepatocellular carcinoma: From diagnosis to emerging therapeutics
Hepatocellular carcinoma: From diagnosis to emerging therapeutics
ajayyadav753
Posterior uveitis (Infective causes) Ophthalmology
Posterior uveitis (Infective causes) OphthalmologyPosterior uveitis (Infective causes) Ophthalmology
Posterior uveitis (Infective causes) Ophthalmology
nirajgoswami99999
Advances in Novel Drug Therapy for Metabolic Dysfunction-associated Steatohep...
Advances in Novel Drug Therapy for Metabolic Dysfunction-associated Steatohep...Advances in Novel Drug Therapy for Metabolic Dysfunction-associated Steatohep...
Advances in Novel Drug Therapy for Metabolic Dysfunction-associated Steatohep...
syedanasir5
Acquired Cataract classification ,risk, mechanism and stages_mbbs.pptx
Acquired Cataract classification ,risk, mechanism and stages_mbbs.pptxAcquired Cataract classification ,risk, mechanism and stages_mbbs.pptx
Acquired Cataract classification ,risk, mechanism and stages_mbbs.pptx
Sourav Choudhari
Ad

Articulo 1

  • 2. a O2 O2.- b O2 O2.- Nox1 p22phox Nox2 p22phox H+ + NADP+ H+ + NADP+ NADPH NOXO1 NADPH P47 NOXA1 P67 phox phox Rac Rac GTP GTP c O2 H2O2 d O2 O2.- O2.- Nox4 p22phox Nox5 Ca2+ H+ + NADP+ H+ + NADP+ NADPH NADPH - -
  • 3. - tat
  • 4. - - - - a b NOX1 NOX2 NOX4 O2.- H2O2 - NO ONOO- Improved Vascular Endothelial endothelial remodeling dysfunction function top Ach Tg SBP DBP P
  • 5. . -- -- . -- . . -- - -- tat
  • 6. b . a a j
  • 7. a WT/Sham KO/Sham WT/Band KO/Band A B C b Stress (hypertension) Myocardial hypoxia Preservation of capillaries Hydroxylated HIF-1留 Nox4 stable HIF-1留 HIF-1 complex VEGF 留 硫 VEGF-HRE WT Panel A scale bar panel B panel C scale bars l .
  • 8. WT . .
  • 9. --
  • 11. --
  • 12. -